4//SEC Filing
Blackley Seth 4
Accession 0001628908-23-000185
CIK 0001628908other
Filed
Dec 5, 7:00 PM ET
Accepted
Dec 6, 4:49 PM ET
Size
13.8 KB
Accession
0001628908-23-000185
Insider Transaction Report
Form 4
Blackley Seth
DirectorChief Executive Officer
Transactions
- Sale
Class A Common Stock
2023-12-05$26.61/sh−92,616$2,464,512→ 658,545 total - Sale
Class A Common Stock
2023-12-05$27.25/sh−20,900$569,525→ 637,645 total - Exercise/Conversion
Class A Common Stock
2023-12-04+280,000→ 778,645 total - Sale
Class A Common Stock
2023-12-05$25.74/sh−27,484$707,438→ 751,161 total - Exercise/Conversion
Leveraged Restricted Stock Unit
2023-12-04−280,000→ 0 totalExercise: $0.00→ Class A Common Stock (280,000 underlying)
Footnotes (10)
- [F1]Represents the vesting of the leveraged stock units ("LSUs") granted to Mr. Blackley on June 4, 2020, based on the cumulative performance of the Issuer's Class A Common Stock.
- [F10]These LSUs do not expire.
- [F2]Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
- [F3]Since the date of the reporting person's last ownership report, Mr. Blackley transferred 284,366 shares of Evolent Health, Inc. Class A Common Stock pursuant to a domestic relations order.
- [F4]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 30, 2023.
- [F5]This number represents shares of Class A Common Stock sold to satisfy the tax withholding obligation due upon vesting of LSUs.
- [F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.05 to $26.04, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F7]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.05 to $27.04, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F8]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.07 to $27.42, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F9]These LSUs vested on December 4, 2023.
Documents
Issuer
Evolent Health, Inc.
CIK 0001628908
Entity typeother
Related Parties
1- filerCIK 0001643346
Filing Metadata
- Form type
- 4
- Filed
- Dec 5, 7:00 PM ET
- Accepted
- Dec 6, 4:49 PM ET
- Size
- 13.8 KB